smti_corresp
Sanara MedTech Inc.
1200 Summit Ave, Suite 414
Fort Worth, Texas 76102
December
30, 2020
VIA EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Washington,
D.C. 20549
Attention:
Tim Buchmiller
Re:
|
Sanara
MedTech Inc.Registration Statement on Form S-3
|
|
Filed
on December 23, 2020
|
|
File
No. 333-251652 (the “Registration
Statement”)
|
|
Request for
Acceleration
|
Ladies
and Gentlemen:
Pursuant to Rule
461 of the Rules and Regulations of the Securities and Exchange
Commission (the “Commission”)
under the Securities Act of 1933, as amended, Sanara MedTech Inc.
(the “Company”)
hereby respectfully requests acceleration of the effective date of
the Registration Statement so that it may become effective at 4:00
p.m., Eastern Time, on January 4, 2021, or as soon thereafter as
practicable.
Should
any member of the staff of the Commission have any questions or
comments with respect to this request, please contact our counsel,
Haynes and Boone, LLP, attention: Matthew L. Fry, Esq. at (214)
651-5443.
|
Very
truly yours,
SANARA
MEDTECH INC.
|
|
|
|
By:
|
/s/
Michael D. McNeil
|
|
|
Michael
D. McNeil
Chief
Financial Officer
|
cc:
Matthew L. Fry,
Esq., Haynes and Boone, LLP